Shares of Senseonics Holdings, a medical technology company focused on the development and manufacturing of continuous glucose monitoring systems, surged 5.78% in pre-market trading on Friday.
HC Wainwright & Co. maintained its "Buy" rating and a $2.00 price target on Senseonics, indicating potential upside for the stock. The analyst action appears to be driving the pre-market rally.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。